AlphaLife Sciences actively participated in the Biotech Showcase 2025, held from January 13 to 15 in San Francisco. CEO Sharon Chen joined the panel discussion titled "Singapore: Launchpad for Life Science Innovation in Asia Pacific," moderated by Sharon Chan, VP of JLABS Asia Pacific. The panel also featured industry leaders such as Huren Sivaraj, Co-Founder and CEO of Oncoshot. The event facilitated discussions on Singapore's role as a regional innovation hub and fostered potential collaborations to strengthen the life sciences ecosystem in the Asia Pacific.
AlphaLife Sciences expands its presence by joining BIO HK 2024, showcasing GenAI-powered solutions for clinical research at this leading biotech event.
At the 2024 SAPA-DC Annual Conference, AlphaLife Sciences CEO Sharon Chen highlighted AuroraPrime, a GenAI-powered platform that automates clinical trial processes. Tools like AuroraPrime Create and AuroraPrime Comprehend streamline document drafting and data monitoring, driving innovation in clinical research through GenAI and strategic partnerships.